Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drug

The Journal of General Virology
A M BormanF Clavel

Abstract

Inhibitors of the human immunodeficiency virus (HIV) protease are a promising class of antiviral agents that dramatically reduce HIV replication both in culture and in infected patients. However, as for many other antiviral compounds, long-term efficacy of these agents is impeded by the emergence of virus variants with increased resistance to their inhibitory action, following selection of specific mutations in the protease coding sequence. We have studied HIV-1 variants that emerged at different stages of selection in the presence of the C2-symmetrical protease inhibitor ABT-77003. The selection of variants was a gradual process during which mutations accumulated at different sites in the protease, generating virus populations with increasing levels of resistance to the drug. The initially selected viruses had a low level of resistance as well as a markedly reduced replicative capacity. Further accumulation of mutations at secondary sites led to an improvement in both drug resistance and replication. In spite of their reduced infectivity, partially selected virus populations did not readily revert to wild-type when serially passaged in drug-free conditions. Instead, even in the absence of drug, secondary mutations identical to...Continue Reading

Citations

Jan 18, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Miguel E Quiñones-Mateu, Eric J Arts
Oct 6, 1999·Current Opinion in Microbiology·D I Andersson, B R Levin
Aug 3, 2005·Nature Reviews. Genetics·Mark A DePristoDaniel L Hartl
Aug 30, 2008·AIDS·Olivier ter BrakeBen Berkhout
Oct 23, 1997·Proceedings. Biological Sciences·S J SchragB R Levin
Oct 26, 2012·Proceedings. Biological Sciences·Susanna Remold
Dec 29, 2000·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·H A WichmanJ J Bull
May 28, 2009·Antimicrobial Agents and Chemotherapy·Michel L NtemgwaMark A Wainberg
Dec 15, 2010·Antimicrobial Agents and Chemotherapy·Chris M ParryDeenan Pillay
Feb 24, 2010·Antimicrobial Agents and Chemotherapy·Pia Schulz zur WieschSebastian Bonhoeffer
Mar 16, 2004·Journal of Virology·Claudia González-LópezEsteban Domingo
Feb 21, 2013·BMC Evolutionary Biology·Stéphanie BedhommeSantiago F Elena
Aug 8, 2012·Retrovirology·Axel FunMonique Nijhuis
Jan 27, 2007·PLoS Medicine·Marc LipsitchBruce R Levin
Jan 18, 2007·PLoS Medicine·Monique NijhuisCharles A B Boucher
Aug 8, 2009·PLoS Pathogens·Linda L MarcussonDiarmaid Hughes
Jan 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Igor M RouzineJohn M Coffin
Aug 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·C G KurlandOtto G Berg
Nov 26, 2002·Molecular Biology and Evolution·Otto G Berg, C G Kurland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.